A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 48,913 shares of SRPT stock, worth $5.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
48,913
Previous 48,913 -0.0%
Holding current value
$5.95 Million
Previous $7.73 Million -0.0%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $5.54 Million - $8.01 Million
48,913 New
48,913 $7.73 Million
Q3 2023

Nov 14, 2023

SELL
$102.5 - $123.59 $2.26 Million - $2.72 Million
-22,026 Reduced 6.69%
307,343 $37.3 Million
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $29.9 Million - $44.2 Million
280,913 Added 579.73%
329,369 $37.7 Million
Q1 2023

May 15, 2023

SELL
$117.53 - $155.99 $77 Million - $102 Million
-655,299 Reduced 93.11%
48,456 $6.68 Million
Q4 2022

Feb 14, 2023

SELL
$100.86 - $132.13 $14.9 Million - $19.6 Million
-148,145 Reduced 17.39%
703,755 $91.2 Million
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $32.3 Million - $50.8 Million
426,393 Added 100.21%
851,900 $94.2 Million
Q2 2022

Aug 15, 2022

SELL
$62.69 - $88.44 $64.1 Million - $90.4 Million
-1,021,704 Reduced 70.6%
425,507 $31.9 Million
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $18.7 Million - $26.8 Million
296,002 Added 25.71%
1,447,211 $113 Million
Q4 2021

Feb 14, 2022

SELL
$77.28 - $99.42 $53.7 Million - $69.1 Million
-694,791 Reduced 37.64%
1,151,209 $104 Million
Q3 2021

Nov 15, 2021

BUY
$65.97 - $92.48 $94.2 Million - $132 Million
1,427,400 Added 340.99%
1,846,000 $171 Million
Q2 2021

Aug 16, 2021

BUY
$69.38 - $86.75 $19.4 Million - $24.3 Million
279,614 Added 201.18%
418,600 $32.5 Million
Q1 2021

May 17, 2021

BUY
$72.25 - $168.95 $10 Million - $23.5 Million
138,986 New
138,986 $10.4 Million
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $28.4 Million - $45.4 Million
-344,710 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$76.53 - $135.58 $26.9 Million - $47.7 Million
-351,975 Reduced 50.52%
344,710 $44.5 Million
Q3 2019

Nov 15, 2019

BUY
$72.81 - $156.91 $50.7 Million - $109 Million
696,685 New
696,685 $52.5 Million
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $29.3 Million - $39.6 Million
-260,790 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $19.5 Million - $27.7 Million
182,897 Added 234.81%
260,790 $31.1 Million
Q4 2018

Feb 14, 2019

BUY
$97.32 - $148.76 $1.18 Million - $1.8 Million
12,123 Added 18.43%
77,893 $8.5 Million
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $23.1 Million - $32.3 Million
-199,991 Reduced 75.25%
65,770 $10.6 Million
Q2 2018

Aug 14, 2018

SELL
$71.74 - $153.69 $22.5 Million - $48.3 Million
-313,996 Reduced 54.16%
265,761 $35.1 Million
Q4 2017

Feb 14, 2018

SELL
$47.64 - $56.75 $50.8 Million - $60.5 Million
-1,065,518 Reduced 64.76%
579,757 $32.3 Million
Q3 2017

Nov 14, 2017

BUY
$35.73 - $47.15 $58.8 Million - $77.6 Million
1,645,275
1,645,275 $74.6 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.6B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.